Siemens to sell microbiology business to Danaher

• As part of a restructuring plan, Siemens (OTCPK:SIEGY) has announced it will sell its microbiology unit to Beckman Coulter, a subsidiary of Danaher (NYSE:DHR). The deal will allow Siemens to concentrate more on its healthcare division's in-vitro business.
• The transaction is expected to close in the first quarter of 2015.